Agios Pharmaceuticals | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.18B 349M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 7.06B 1.83B 2025-06
Bayer EUR 4.02B 2.18B 2025-03
Biogen USD 2.76B 160.5M 2025-06
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Exelixis USD 164.43M 19.32M 2025-06
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 3.6B 865M 2025-06
Incyte USD 2.42B 13.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Novartis USD 6.66B 410M 2025-06
Novartis USD 11.46B 2.15B 2024-12
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12


Agios Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.